Dalia ElMofty, M.D.

Assistant Professor of Anesthesia & Critical Care

5841 S. Maryland Ave.
M.C. 4028
Chicago, IL 60637

(773) 702-6333

Training

M.D. - 1991 - 1997
Ain Shams University - Abbasaya, Cairo Egypt

Internship - 2004 - 2005
Rush University Medical Center - Chicago, IL USA - Anesthesiology

Residency - 1999 - 2001
Ain Shams University Abassaya, Cairo Egypt - Clinical Pathology

Residency - 2005 - 2008
Rush University Medical Center - Chicago, IL USA - Anesthesiology

Fellowship - 2008 - 2009
Rush University Medical Center - Chicago , IL USA - Pain Medicine

Clinical Interests

Acute and Chronic Pain Management in adult and pediatric population
Interventional Pain Procedures
Ultrasound guided Regional Anesthesia

Academic Interests

Multi-institutional approach for pain fellowship education
Educating anesthesia, non-anesthesia residents and medical students pain management
Multimodal approaches for acute and chronic pain management

Recent Publications

Elmofty D, Cutter T. Overview of a General Anesthetic.The Anesthesia Technician and Technologist's Manual: All You Need to Know for Study and Reference. Woodworth G, Kirsch J, eds. Lippincott Williams & Wilkins (2011, In press)

Buvanendran A, Kroin JS, Tuman KJ, Lubenow TR, Elmofty D, Moric M, Rosenbergy AG: Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial. JAMA 290:2411-2418, 2003

Buvanendran A, Kroin JS, Tuman KJ, Lubenow TR, Elmofty D, Luk P: Cerebrospinal fluid and plasma pharmacokinetics of the cyclooxygenase 2 inhibitor rofecoxib in humans: single and multiple oral drug administration. Anesth Analg 100:1320-1324, 2005

Buvanendran A, Elmofty D, Lubenow TJ, Kroin JS, Tuman KJ: Perioperative administration of selective cyclooxygenase-2 (cox- 2) inhibitor reduces postoperative epidural drug consumption after total knee arthroplasty (TKA). Anesthesiology 96:A943, 2002

Buvanendran A, Elmofty D, Tuman KJ, Sheinkop M, Kroin JS: Administration of selective cyclooxygenase-2 (COX-2) inhibitor with warfarin does not increase blood loss following total knee arthroplasty (TKA). Anesthesiology 96:A942, 2002

Buvanendran A, Elmofty D, Moric M, Kroin JS, Tuman KJ: Rofecoxib reduces postoperative opioid consumption and improves range of motion after total knee arthroplasty (TKA). Anesthesiology 99:A1116, 2003

Buvanendran A, Elmofty D, Moric M, Kroin JS, Tuman KJ: Perioperative administration of a selective cyclooxygenase-2 inhibitor reduces postoperative sleep disturbance and improves satisfaction after total knee arthroplasty (TKA). Anesthesiology 99:A974, 2003

Buvanendran A, Moric M, Elmofty D, Kroin JS, Tuman KJ: The effect of acute postoperative pain on range of motion at time of discharge after total knee arthroplasty. Anesth Analg 96:S203, 2003

Buvanendran A, Kroin JS, Elmofty D, Saha C, Tuman KJ: Human Blood-Brain-Barrier Penetration of Oral Rofecoxib, a selective Cyclooxygenase-2 (COX-2) inhibitor: Single Dose Pharmacokinetic Study. Reg Anesth Pain Med 29(2):A20, 2004

Buvanendran A, Elmofty D, Moric M, Kroin JS, Tuman KJ. Reduction in postoperative nausea and vomiting following preoperative and postoperative administration of rofecoxib for total knee arthroplasty. Anesth Analg 98:S178, 2004

Buvanendran A, Moric M, Elmofty D, Kroin JS, Tuman KT. Patient satisfaction with analgesia after preoperative and postoperative administration of rofecoxib. Anesth Analg 98:S199, 2004